Global CRO in Clinical Trials Supply, Demand and Key Producers, 2024-2030

Description

The global CRO in Clinical Trials market size is expected to reach $ 89680 million by 2030, rising at a market growth of 9.3% CAGR during the forecast period (2024-2030).

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries. Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others. In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor’s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).

Global core CRO in clinical trials players include Labcorp, IQVIA and Parexel etc. The top 5 companies hold a share about 40%. North America is the largest market, with a share about 45%, followed by Europe and Asia Pacific with the share about 35% and 20%. In terms of product, phase iii trial is the largest segment, with a share about 35%. And in terms ofend users, the largest end user is pharmaceutical，with a share about 55%.

The market for Contract Research Organizations (CROs) in clinical trials is experiencing significant growth and evolution due to various factors:
Biopharmaceutical Companies: Many pharma and biotech firms are increasingly outsourcing clinical trials to CROs to reduce costs, improve efficiency, and tap into specialized expertise. This trend is particularly notable among smaller biotech companies with limited infrastructure.

Focus on Core Competencies: Large pharmaceutical companies prefer focusing on core R&D activities, delegating clinical trial processes to CROs for scalability and cost-effectiveness.

Decentralized Clinical Trials (DCTs): CROs are innovating with decentralized trial models, enabling remote patient monitoring and data collection. This trend has accelerated post-COVID-19, enhancing patient recruitment, retention, and trial accessibility.

Adaptive and Hybrid Trials: The need for quicker, adaptable trials that can respond to real-time data is driving hybrid and adaptive trial designs. CROs are investing in capabilities to support these complex trial models.

Expanding Trials in APAC and LATAM: CROs are increasingly establishing operations in Asia-Pacific, Latin America, and Eastern Europe, where costs are lower, and recruitment pools are larger.

Regulatory Alignment: Many countries are harmonizing their regulatory requirements with global standards, making it easier for CROs to conduct trials internationally.

Artificial Intelligence (AI) and Machine Learning (ML): CROs are adopting AI/ML for predictive modeling, patient recruitment, trial monitoring, and data analysis, increasing accuracy and efficiency.

Digital Health Technologies: Wearable devices and digital health tools for real-time data capture are becoming integral in trials, supporting both remote and hybrid trial models.

Specialized Trials: Growth in oncology and rare disease research, which often require specialized trial designs and complex patient recruitment, is pushing CROs to develop niche expertise.

Patient-Centric Approaches: CROs are focusing on patient-centric methods to enhance participation and retention, especially in studies with rare or hard-to-reach patient populations.

Compliance and Quality Control: As regulations become more stringent, CROs are enhancing their quality assurance programs to ensure compliance with Good Clinical Practice (GCP) and international standards.

Data Security and Privacy: CROs are also adapting to increased demands for data privacy, especially with the rise in remote and decentralized trials.

This report studies the global CRO in Clinical Trials demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CRO in Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CRO in Clinical Trials that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CRO in Clinical Trials total market, 2019-2030, (USD Million)
Global CRO in Clinical Trials total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CRO in Clinical Trials total market, key domestic companies, and share, (USD Million)
Global CRO in Clinical Trials revenue by player, revenue and market share 2019-2024, (USD Million)
Global CRO in Clinical Trials total market by Type, CAGR, 2019-2030, (USD Million)
Global CRO in Clinical Trials total market by Application, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global CRO in Clinical Trials market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, Medpace Holdings, Wuxi Apptec, Tigermed, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world CRO in Clinical Trials market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global CRO in Clinical Trials Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global CRO in Clinical Trials Market, Segmentation by Type
    Phase I Trial
    Phase II Trial
    Phase III Trial
    Phase IV Trial

Global CRO in Clinical Trials Market, Segmentation by Application:
    Pharmaceutical
    Bio-pharm
    Others

Companies Profiled:
    Labcorp
    IQVIA
    Parexel
    Syneos Health
    PRA Health Sciences
    PPD
    ICON
    Medpace Holdings
    Wuxi Apptec
    Tigermed
    Boji Medical Technology
    Pharmaron

Key Questions Answered
1. How big is the global CRO in Clinical Trials market?
2. What is the demand of the global CRO in Clinical Trials market?
3. What is the year over year growth of the global CRO in Clinical Trials market?
4. What is the total value of the global CRO in Clinical Trials market?
5. Who are the Major Players in the global CRO in Clinical Trials market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 CRO in Clinical Trials Introduction
    1.2 World CRO in Clinical Trials Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World CRO in Clinical Trials Total Market by Region (by Headquarter Location)
        1.3.1 World CRO in Clinical Trials Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company CRO in Clinical Trials Revenue (2019-2030)
        1.3.3 China Based Company CRO in Clinical Trials Revenue (2019-2030)
        1.3.4 Europe Based Company CRO in Clinical Trials Revenue (2019-2030)
        1.3.5 Japan Based Company CRO in Clinical Trials Revenue (2019-2030)
        1.3.6 South Korea Based Company CRO in Clinical Trials Revenue (2019-2030)
        1.3.7 ASEAN Based Company CRO in Clinical Trials Revenue (2019-2030)
        1.3.8 India Based Company CRO in Clinical Trials Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CRO in Clinical Trials Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World CRO in Clinical Trials Consumption Value (2019-2030)
    2.2 World CRO in Clinical Trials Consumption Value by Region
        2.2.1 World CRO in Clinical Trials Consumption Value by Region (2019-2024)
        2.2.2 World CRO in Clinical Trials Consumption Value Forecast by Region (2025-2030)
    2.3 United States CRO in Clinical Trials Consumption Value (2019-2030)
    2.4 China CRO in Clinical Trials Consumption Value (2019-2030)
    2.5 Europe CRO in Clinical Trials Consumption Value (2019-2030)
    2.6 Japan CRO in Clinical Trials Consumption Value (2019-2030)
    2.7 South Korea CRO in Clinical Trials Consumption Value (2019-2030)
    2.8 ASEAN CRO in Clinical Trials Consumption Value (2019-2030)
    2.9 India CRO in Clinical Trials Consumption Value (2019-2030)

3 World CRO in Clinical Trials Companies Competitive Analysis
    3.1 World CRO in Clinical Trials Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CRO in Clinical Trials Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CRO in Clinical Trials in 2023
        3.2.3 Global Concentration Ratios (CR8) for CRO in Clinical Trials in 2023
    3.3 CRO in Clinical Trials Company Evaluation Quadrant
    3.4 CRO in Clinical Trials Market: Overall Company Footprint Analysis
        3.4.1 CRO in Clinical Trials Market: Region Footprint
        3.4.2 CRO in Clinical Trials Market: Company Product Type Footprint
        3.4.3 CRO in Clinical Trials Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: CRO in Clinical Trials Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CRO in Clinical Trials Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: CRO in Clinical Trials Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: CRO in Clinical Trials Consumption Value Comparison
        4.2.1 United States VS China: CRO in Clinical Trials Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: CRO in Clinical Trials Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based CRO in Clinical Trials Companies and Market Share, 2019-2024
        4.3.1 United States Based CRO in Clinical Trials Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CRO in Clinical Trials Revenue, (2019-2024)
    4.4 China Based Companies CRO in Clinical Trials Revenue and Market Share, 2019-2024
        4.4.1 China Based CRO in Clinical Trials Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CRO in Clinical Trials Revenue, (2019-2024)
    4.5 Rest of World Based CRO in Clinical Trials Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based CRO in Clinical Trials Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies CRO in Clinical Trials Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World CRO in Clinical Trials Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Phase I Trial
        5.2.2 Phase II Trial
        5.2.3 Phase III Trial
        5.2.4 Phase IV Trial
    5.3 Market Segment by Type
        5.3.1 World CRO in Clinical Trials Market Size by Type (2019-2024)
        5.3.2 World CRO in Clinical Trials Market Size by Type (2025-2030)
        5.3.3 World CRO in Clinical Trials Market Size Market Share by Type (2025-2030)

6 Market Analysis by Application
    6.1 World CRO in Clinical Trials Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical
        6.2.2 Bio-pharm
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World CRO in Clinical Trials Market Size by Application (2019-2024)
        6.3.2 World CRO in Clinical Trials Market Size by Application (2025-2030)
        6.3.3 World CRO in Clinical Trials Market Size Market Share by Application (2019-2030)

7 Company Profiles
    7.1 Labcorp
        7.1.1 Labcorp Details
        7.1.2 Labcorp Major Business
        7.1.3 Labcorp CRO in Clinical Trials Product and Services
        7.1.4 Labcorp CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Labcorp Recent Developments/Updates
        7.1.6 Labcorp Competitive Strengths & Weaknesses
    7.2 IQVIA
        7.2.1 IQVIA Details
        7.2.2 IQVIA Major Business
        7.2.3 IQVIA CRO in Clinical Trials Product and Services
        7.2.4 IQVIA CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 IQVIA Recent Developments/Updates
        7.2.6 IQVIA Competitive Strengths & Weaknesses
    7.3 Parexel
        7.3.1 Parexel Details
        7.3.2 Parexel Major Business
        7.3.3 Parexel CRO in Clinical Trials Product and Services
        7.3.4 Parexel CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Parexel Recent Developments/Updates
        7.3.6 Parexel Competitive Strengths & Weaknesses
    7.4 Syneos Health
        7.4.1 Syneos Health Details
        7.4.2 Syneos Health Major Business
        7.4.3 Syneos Health CRO in Clinical Trials Product and Services
        7.4.4 Syneos Health CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Syneos Health Recent Developments/Updates
        7.4.6 Syneos Health Competitive Strengths & Weaknesses
    7.5 PRA Health Sciences
        7.5.1 PRA Health Sciences Details
        7.5.2 PRA Health Sciences Major Business
        7.5.3 PRA Health Sciences CRO in Clinical Trials Product and Services
        7.5.4 PRA Health Sciences CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 PRA Health Sciences Recent Developments/Updates
        7.5.6 PRA Health Sciences Competitive Strengths & Weaknesses
    7.6 PPD
        7.6.1 PPD Details
        7.6.2 PPD Major Business
        7.6.3 PPD CRO in Clinical Trials Product and Services
        7.6.4 PPD CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 PPD Recent Developments/Updates
        7.6.6 PPD Competitive Strengths & Weaknesses
    7.7 ICON
        7.7.1 ICON Details
        7.7.2 ICON Major Business
        7.7.3 ICON CRO in Clinical Trials Product and Services
        7.7.4 ICON CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 ICON Recent Developments/Updates
        7.7.6 ICON Competitive Strengths & Weaknesses
    7.8 Medpace Holdings
        7.8.1 Medpace Holdings Details
        7.8.2 Medpace Holdings Major Business
        7.8.3 Medpace Holdings CRO in Clinical Trials Product and Services
        7.8.4 Medpace Holdings CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Medpace Holdings Recent Developments/Updates
        7.8.6 Medpace Holdings Competitive Strengths & Weaknesses
    7.9 Wuxi Apptec
        7.9.1 Wuxi Apptec Details
        7.9.2 Wuxi Apptec Major Business
        7.9.3 Wuxi Apptec CRO in Clinical Trials Product and Services
        7.9.4 Wuxi Apptec CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Wuxi Apptec Recent Developments/Updates
        7.9.6 Wuxi Apptec Competitive Strengths & Weaknesses
    7.10 Tigermed
        7.10.1 Tigermed Details
        7.10.2 Tigermed Major Business
        7.10.3 Tigermed CRO in Clinical Trials Product and Services
        7.10.4 Tigermed CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Tigermed Recent Developments/Updates
        7.10.6 Tigermed Competitive Strengths & Weaknesses
    7.11 Boji Medical Technology
        7.11.1 Boji Medical Technology Details
        7.11.2 Boji Medical Technology Major Business
        7.11.3 Boji Medical Technology CRO in Clinical Trials Product and Services
        7.11.4 Boji Medical Technology CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Boji Medical Technology Recent Developments/Updates
        7.11.6 Boji Medical Technology Competitive Strengths & Weaknesses
    7.12 Pharmaron
        7.12.1 Pharmaron Details
        7.12.2 Pharmaron Major Business
        7.12.3 Pharmaron CRO in Clinical Trials Product and Services
        7.12.4 Pharmaron CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Pharmaron Recent Developments/Updates
        7.12.6 Pharmaron Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CRO in Clinical Trials Industry Chain
    8.2 CRO in Clinical Trials Upstream Analysis
    8.3 CRO in Clinical Trials Midstream Analysis
    8.4 CRO in Clinical Trials Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World CRO in Clinical Trials Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World CRO in Clinical Trials Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World CRO in Clinical Trials Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World CRO in Clinical Trials Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World CRO in Clinical Trials Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World CRO in Clinical Trials Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World CRO in Clinical Trials Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World CRO in Clinical Trials Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World CRO in Clinical Trials Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key CRO in Clinical Trials Players in 2023
 Table 12. World CRO in Clinical Trials Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global CRO in Clinical Trials Company Evaluation Quadrant
 Table 14. Head Office of Key CRO in Clinical Trials Players
 Table 15. CRO in Clinical Trials Market: Company Product Type Footprint
 Table 16. CRO in Clinical Trials Market: Company Product Application Footprint
 Table 17. CRO in Clinical Trials Mergers & Acquisitions Activity
 Table 18. United States VS China CRO in Clinical Trials Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China CRO in Clinical Trials Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based CRO in Clinical Trials Companies, Headquarters (States, Country)
 Table 21. United States Based Companies CRO in Clinical Trials Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies CRO in Clinical Trials Revenue Market Share (2019-2024)
 Table 23. China Based CRO in Clinical Trials Companies, Headquarters (Province, Country)
 Table 24. China Based Companies CRO in Clinical Trials Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies CRO in Clinical Trials Revenue Market Share (2019-2024)
 Table 26. Rest of World Based CRO in Clinical Trials Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies CRO in Clinical Trials Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies CRO in Clinical Trials Revenue Market Share (2019-2024)
 Table 29. World CRO in Clinical Trials Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World CRO in Clinical Trials Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World CRO in Clinical Trials Market Size by Type (2025-2030) & (USD Million)
 Table 32. World CRO in Clinical Trials Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Table 33. World CRO in Clinical Trials Market Size by Application (2019-2024) & (USD Million)
 Table 34. World CRO in Clinical Trials Market Size by Application (2025-2030) & (USD Million)
 Table 35. Labcorp Basic Information, Manufacturing Base and Competitors
 Table 36. Labcorp Major Business
 Table 37. Labcorp CRO in Clinical Trials Product and Services
 Table 38. Labcorp CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Labcorp Recent Developments/Updates
 Table 40. Labcorp Competitive Strengths & Weaknesses
 Table 41. IQVIA Basic Information, Manufacturing Base and Competitors
 Table 42. IQVIA Major Business
 Table 43. IQVIA CRO in Clinical Trials Product and Services
 Table 44. IQVIA CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. IQVIA Recent Developments/Updates
 Table 46. IQVIA Competitive Strengths & Weaknesses
 Table 47. Parexel Basic Information, Manufacturing Base and Competitors
 Table 48. Parexel Major Business
 Table 49. Parexel CRO in Clinical Trials Product and Services
 Table 50. Parexel CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. Parexel Recent Developments/Updates
 Table 52. Parexel Competitive Strengths & Weaknesses
 Table 53. Syneos Health Basic Information, Manufacturing Base and Competitors
 Table 54. Syneos Health Major Business
 Table 55. Syneos Health CRO in Clinical Trials Product and Services
 Table 56. Syneos Health CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Syneos Health Recent Developments/Updates
 Table 58. Syneos Health Competitive Strengths & Weaknesses
 Table 59. PRA Health Sciences Basic Information, Manufacturing Base and Competitors
 Table 60. PRA Health Sciences Major Business
 Table 61. PRA Health Sciences CRO in Clinical Trials Product and Services
 Table 62. PRA Health Sciences CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. PRA Health Sciences Recent Developments/Updates
 Table 64. PRA Health Sciences Competitive Strengths & Weaknesses
 Table 65. PPD Basic Information, Manufacturing Base and Competitors
 Table 66. PPD Major Business
 Table 67. PPD CRO in Clinical Trials Product and Services
 Table 68. PPD CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. PPD Recent Developments/Updates
 Table 70. PPD Competitive Strengths & Weaknesses
 Table 71. ICON Basic Information, Manufacturing Base and Competitors
 Table 72. ICON Major Business
 Table 73. ICON CRO in Clinical Trials Product and Services
 Table 74. ICON CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. ICON Recent Developments/Updates
 Table 76. ICON Competitive Strengths & Weaknesses
 Table 77. Medpace Holdings Basic Information, Manufacturing Base and Competitors
 Table 78. Medpace Holdings Major Business
 Table 79. Medpace Holdings CRO in Clinical Trials Product and Services
 Table 80. Medpace Holdings CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Medpace Holdings Recent Developments/Updates
 Table 82. Medpace Holdings Competitive Strengths & Weaknesses
 Table 83. Wuxi Apptec Basic Information, Manufacturing Base and Competitors
 Table 84. Wuxi Apptec Major Business
 Table 85. Wuxi Apptec CRO in Clinical Trials Product and Services
 Table 86. Wuxi Apptec CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Wuxi Apptec Recent Developments/Updates
 Table 88. Wuxi Apptec Competitive Strengths & Weaknesses
 Table 89. Tigermed Basic Information, Manufacturing Base and Competitors
 Table 90. Tigermed Major Business
 Table 91. Tigermed CRO in Clinical Trials Product and Services
 Table 92. Tigermed CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Tigermed Recent Developments/Updates
 Table 94. Tigermed Competitive Strengths & Weaknesses
 Table 95. Boji Medical Technology Basic Information, Manufacturing Base and Competitors
 Table 96. Boji Medical Technology Major Business
 Table 97. Boji Medical Technology CRO in Clinical Trials Product and Services
 Table 98. Boji Medical Technology CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Boji Medical Technology Recent Developments/Updates
 Table 100. Boji Medical Technology Competitive Strengths & Weaknesses
 Table 101. Pharmaron Basic Information, Manufacturing Base and Competitors
 Table 102. Pharmaron Major Business
 Table 103. Pharmaron CRO in Clinical Trials Product and Services
 Table 104. Pharmaron CRO in Clinical Trials Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Pharmaron Recent Developments/Updates
 Table 106. Pharmaron Competitive Strengths & Weaknesses
 Table 107. Global Key Players of CRO in Clinical Trials Upstream (Raw Materials)
 Table 108. Global CRO in Clinical Trials Typical Customers


List of Figures
 Figure 1. CRO in Clinical Trials Picture
 Figure 2. World CRO in Clinical Trials Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World CRO in Clinical Trials Total Revenue (2019-2030) & (USD Million)
 Figure 4. World CRO in Clinical Trials Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World CRO in Clinical Trials Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company CRO in Clinical Trials Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company CRO in Clinical Trials Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company CRO in Clinical Trials Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company CRO in Clinical Trials Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company CRO in Clinical Trials Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company CRO in Clinical Trials Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company CRO in Clinical Trials Revenue (2019-2030) & (USD Million)
 Figure 13. CRO in Clinical Trials Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 16. World CRO in Clinical Trials Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 18. China CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 23. India CRO in Clinical Trials Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of CRO in Clinical Trials by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for CRO in Clinical Trials Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for CRO in Clinical Trials Markets in 2023
 Figure 27. United States VS China: CRO in Clinical Trials Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: CRO in Clinical Trials Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World CRO in Clinical Trials Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World CRO in Clinical Trials Market Size Market Share by Type in 2023
 Figure 31. Phase I Trial
 Figure 32. Phase II Trial
 Figure 33. Phase III Trial
 Figure 34. Phase IV Trial
 Figure 35. World CRO in Clinical Trials Market Size Market Share by Type (2019-2030)
 Figure 36. World CRO in Clinical Trials Market Size by Application, (USD Million), 2019 & 2023 & 2030
 Figure 37. World CRO in Clinical Trials Market Size Market Share by Application in 2023
 Figure 38. Pharmaceutical
 Figure 39. Bio-pharm
 Figure 40. Others
 Figure 41. World CRO in Clinical Trials Market Size Market Share by Application (2019-2030)
 Figure 42. CRO in Clinical Trials Industrial Chain
 Figure 43. Methodology
 Figure 44. Research Process and Data Source

Companies Mentioned

Labcorp
IQVIA
Parexel
Syneos Health
PRA Health Sciences
PPD
ICON
Medpace Holdings
Wuxi Apptec
Tigermed
Boji Medical Technology
Pharmaron